rhinosinusitis%20-%20acute,%20bacterial%20(pediatric)
RHINOSINUSITIS - ACUTE, BACTERIAL (PEDIATRIC)
Rhinosinusitis is the mucosal inflammation of the nose and paranasal sinuses caused by bacteria lasting >10 days for up to 4 weeks, symptoms resolve completely and may either be persistent or severe.
It is often preceded by a viral upper respiratory tract infection.
Signs & symptoms are nonspecific and it is typically difficult to differentiate from viral upper respiratory tract infection.
Streptococcus pneumoniae is the most common cause followed by nontypeable Haemophilus influenzae.

Patient Education

  • Reassure & educate the patient/parent about the nature of upper respiratory infection (URTI) & acute bacterial rhinosinusitis (ABRS), & expected duration of illness
    • May also inform about the details of therapy, role of antibiotics & bacterial resistance
  • Maintain adequate hydration by drinking 6-10 glasses of water/day to thin the mucus
  • Avoidance of exposure to cigarette smoke
  • Steamy baths: Inhaled steam (from a hot bath/shower) may loosen secretions
  • Apply warm facial packs (eg warm wash cloth, hot water bottle) for 5-10 minutes ≥3x/day to promote drainage of mucus & provide some localized relief
  • Consider nasal sprays, saline irrigation & mist humidification
    • There’s no difference in symptoms score when comparing isotonic w/ hypertonic saline, although hypertonic solutions have been shown to improve mucociliary clearance
    • Provides moisture & reduces symptoms
  • Adequate rest
  • Sleep with head elevated to promote drainage of the sinuses or lay patient on the side to ease breathing

Prevention

  • Appropriate management of allergies & viral URTI (eg frequent handwashing)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 4 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

07 Jun 2019
Low-dose aspirin therapy does not confer significant benefits to elderly patients with hypertension, but treatment appears to increase the risk of haemorrhagic events, suggest a Japan study.
4 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.